Sruthi Sritharan
Impact in
-
- Nanoparticle-Based Drug Delivery
Papers in
- Oncology 4
- Colorectal Cancer Treatments and Studies 1
- Cytokine Signaling Pathways and Interactions 1
-
- Chemotherapy-induced cardiotoxicity and mitigation 3
- Co-authors
- N Sivalingam (7 shared papers)
- Journals
- Clinical & Translational Oncology (1 paper)APOPTOSIS (1 paper)Life Sciences (1 paper)Journal of Biochemical and Molecular Toxicology (1 paper)Molecular Biology Reports (1 paper)
- Partner nations
- India
In The Last Decade
Sruthi Sritharan
7 papers receiving 355 citations
Sruthi Sritharan's Hit Papers
Peers
Comparison fields: 5 of 81
- Biomaterials 82
- Drug Discovery 1
- Molecular Medicine 22
- Toxicology 12
- Oncology 67
Countries citing papers authored by Sruthi Sritharan
This map shows the geographic impact of Sruthi Sritharan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sruthi Sritharan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sruthi Sritharan more than expected).
Fields of papers citing papers by Sruthi Sritharan
This network shows the impact of papers produced by Sruthi Sritharan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sruthi Sritharan. The network helps show where Sruthi Sritharan may publish in the future.
Co-authors
The 1 scholars most cited alongside Sruthi Sritharan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A comprehensive review on time-tested anticancer drug doxorubicin Hit paper breakdown → | 2021 | 310 |
| 2 | 2020 | 23 | |
| 3 | 2020 | 13 | |
| 4 | 2022 | 9 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2025 | 1 |
About Sruthi Sritharan
Sruthi Sritharan is a scholar working on Oncology, Cardiology and Cardiovascular Medicine, Biomaterials, Cancer Research and Molecular Biology, having authored 7 papers that have together received 358 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (3 papers), Chemotherapy-induced cardiotoxicity and mitigation (3 papers), Cancer-related cognitive impairment studies (2 papers), Colorectal Cancer Treatments and Studies (1 paper), Cytokine Signaling Pathways and Interactions (1 paper), TGF-β signaling in diseases (1 paper), Cancer, Hypoxia, and Metabolism (1 paper) and Genetic factors in colorectal cancer (1 paper). The work is most often cited by research in Biomaterials (82 citations), Drug Discovery (1 citation), Molecular Medicine (22 citations), Toxicology (12 citations) and Oncology (67 citations). Sruthi Sritharan has collaborated with scholars based in India. Frequent co-authors include N Sivalingam. Their work appears in journals such as Clinical & Translational Oncology, APOPTOSIS, Life Sciences, Journal of Biochemical and Molecular Toxicology and Molecular Biology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.